These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 7733607)
1. [Implantable insulin pump: the first step towards an artificial pancreas]. Vix M; Mutter D; Jeandidier N; Boivin S; Pinget M; Marescaux J Ann Chir; 1994; 48(11):991-7. PubMed ID: 7733607 [TBL] [Abstract][Full Text] [Related]
2. [A promising alternative for the treatment of type I diabetes. The implantable insulin pump]. Marescaux J; Vix M; Mutter D; Jeandidier N; Boivin S; Pinget M Chirurgie; 1993-1994; 119(9):579-84; discussion 584-5. PubMed ID: 7729209 [TBL] [Abstract][Full Text] [Related]
3. Clinical trial of programmable implantable insulin pump for type I diabetes. Selam JL; Micossi P; Dunn FL; Nathan DM Diabetes Care; 1992 Jul; 15(7):877-85. PubMed ID: 1516508 [TBL] [Abstract][Full Text] [Related]
4. Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience. Gin H; Renard E; Melki V; Boivin S; Schaepelynck-Bélicar P; Guerci B; Selam JL; Brun JM; Riveline JP; Estour B; Catargi B; Diabetes Metab; 2003 Dec; 29(6):602-7. PubMed ID: 14707889 [TBL] [Abstract][Full Text] [Related]
5. [Remission of severe hypoglycemic incidents in young diabetic children treated with subcutaneous infusion]. Tubiana-Rufi N; de Lonlay P; Bloch J; Czernichow P Arch Pediatr; 1996 Oct; 3(10):969-76. PubMed ID: 8952790 [TBL] [Abstract][Full Text] [Related]
6. Implantable programmable insulin pumps for the treatment of diabetes. Waxman K; Turner D; Nguyen ST; Selam JL; Charles MA Arch Surg; 1992 Sep; 127(9):1032-6; discussion 1036-7. PubMed ID: 1387526 [TBL] [Abstract][Full Text] [Related]
7. Long-term therapy of IDDM with an implantable insulin pump. The Implantable Insulin Pump Trial Study Group. Dunn FL; Nathan DM; Scavini M; Selam JL; Wingrove TG Diabetes Care; 1997 Jan; 20(1):59-63. PubMed ID: 9028695 [TBL] [Abstract][Full Text] [Related]
8. French multicentre experience of implantable insulin pumps. The EVADIAC Study Group. Evaluation of Active Implants in Diabetes Society. Broussolle C; Jeandidier N; Hanaire-Broutin H Lancet; 1994 Feb; 343(8896):514-5. PubMed ID: 7906761 [TBL] [Abstract][Full Text] [Related]
9. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967 [TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France. Roze S; Smith-Palmer J; Valentine W; Payet V; de Portu S; Papo N; Cucherat M; Hanaire H Diabetes Technol Ther; 2016 Feb; 18(2):75-84. PubMed ID: 26646072 [TBL] [Abstract][Full Text] [Related]
11. Assessment of a new insulin preparation for implanted pumps used in the treatment of type 1 diabetes. Schaepelynck P; Riveline JP; Renard E; Hanaire H; Guerci B; Baillot-Rudoni S; Sola-Gazagnes A; Catargi B; Fontaine P; Millot L; Martin JF; Tachouaft H; Jeandidier N; Diabetes Technol Ther; 2014 Sep; 16(9):582-9. PubMed ID: 24735100 [TBL] [Abstract][Full Text] [Related]
12. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients. Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of MiniMed 640G with SmartGuard® System for prevention of hypoglycemia in pediatric patients with type 1 diabetes mellitus. Villafuerte Quispe B; Martín Frías M; Roldán Martín MB; Yelmo Valverde R; Álvarez Gómez MÁ; Barrio Castellanos R Endocrinol Diabetes Nutr; 2017 Apr; 64(4):198-203. PubMed ID: 28417874 [TBL] [Abstract][Full Text] [Related]
14. Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group. Saudek CD; Duckworth WC; Giobbie-Hurder A; Henderson WG; Henry RR; Kelley DE; Edelman SV; Zieve FJ; Adler RA; Anderson JW; Anderson RJ; Hamilton BP; Donner TW; Kirkman MS; Morgan NA JAMA; 1996 Oct 23-30; 276(16):1322-7. PubMed ID: 8861991 [TBL] [Abstract][Full Text] [Related]
15. Threshold-based insulin-pump interruption for reduction of hypoglycemia. Bergenstal RM; Klonoff DC; Garg SK; Bode BW; Meredith M; Slover RH; Ahmann AJ; Welsh JB; Lee SW; Kaufman FR; N Engl J Med; 2013 Jul; 369(3):224-32. PubMed ID: 23789889 [TBL] [Abstract][Full Text] [Related]
16. [The implantable insulin pump in the treatment of diabetes. Hopes and reality?]. Vague P; Lassmann-Vague V; Belicar P; Alessis C Bull Acad Natl Med; 1996 Apr; 180(4):831-41; discussion 841-3. PubMed ID: 8925331 [TBL] [Abstract][Full Text] [Related]
17. Outpatient 60-hour day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or sensor-augmented pump therapy in adults with type 1 diabetes: An open-label, randomised, crossover, controlled trial. Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R Diabetes Obes Metab; 2017 May; 19(5):713-720. PubMed ID: 28094472 [TBL] [Abstract][Full Text] [Related]
18. Advances toward the implantable artificial pancreas for treatment of diabetes. Jaremko J; Rorstad O Diabetes Care; 1998 Mar; 21(3):444-50. PubMed ID: 9540030 [TBL] [Abstract][Full Text] [Related]
19. A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. Breton MD; Kanapka LG; Beck RW; Ekhlaspour L; Forlenza GP; Cengiz E; Schoelwer M; Ruedy KJ; Jost E; Carria L; Emory E; Hsu LJ; Oliveri M; Kollman CC; Dokken BB; Weinzimer SA; DeBoer MD; Buckingham BA; Cherñavvsky D; Wadwa RP; N Engl J Med; 2020 Aug; 383(9):836-845. PubMed ID: 32846062 [TBL] [Abstract][Full Text] [Related]
20. Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study. Charleer S; De Block C; Nobels F; Radermecker RP; Lowyck I; Mullens A; Scarnière D; Spincemaille K; Strivay M; Weber E; Taes Y; Vercammen C; Keymeulen B; Mathieu C; Gillard P; Diabetes Care; 2020 Dec; 43(12):3016-3023. PubMed ID: 33067260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]